Key result
Adding NT-proBNP to ambulatory blood pressure models significantly improved net reclassification for incident ASCVD (+18.7%-19.9%, P<0.01) in elderly men.
Why the study?
Does the addition of NT-proBNP to ambulatory blood pressure improve risk prediction for incident ASCVD in elderly men?
Cohort (n=907)
Does the addition of NT-proBNP to ambulatory blood pressure improve risk prediction for incident ASCVD in elderly men?
The combination of 24-hour systolic blood pressure and NT-proBNP improves discrimination and net reclassification for incident ASCVD compared with office systolic blood pressure in elderly men.
Answers are grounded in this paper and cite their sources.
May support refined ASCVD risk stratification in elderly men; hypothesis-generating and requires prospective validation before practice change.
Improvement of risk prediction for atherosclerotic cardiovascular disease (ASCVD) is needed. Both ambulatory blood pressure (ABP) and biomarkers amino-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein and cystatin C improve risk prediction but they have not been evaluated in relation to each other. We analyzed whether NT-proBNP, high-sensitivity C-reactive protein, or cystatin C improved risk prediction beyond traditional ASCVD risk factors combined with 24-hour systolic BP (SBP). Secondary aim was to evaluate whether ABP improved risk prediction when compared with models with the biomarkers. We followed up 907 70-year-old men, free of baseline disease, for incident ASCVD defined as fatal or nonfatal myocardial infarction or fatal or nonfatal stroke for a median of 10 years. Cox regression was used to estimate the association between variables in the models and incident ASCVD. Biomarkers were added to a model containing both traditional risk factors and ABP and the models were compared on C-statistics and net reclassification improvement. Twenty-four hour SBP improved discrimination for incident ASCVD when compared with office SBP in a traditional risk factor model (area under the receiver-operating characteristic curve, +2.4%). NT-proBNP further improved reclassification (+18.7%-19.9%; P<0.01) when added to ABP models, whereas high-sensitivity C-reactive protein and cystatin C did not. Twenty-four hour SBP significantly improved net reclassification when added to a traditional risk factor model that included NT-proBNP. The combination of 24-hour SBP and NT-proBNP improved discrimination and net reclassification for incident ASCVD when compared with office SBP in elderly men. NT-proBNP, but not high-sensitivity C-reactive protein or cystatin C, improved risk prediction and discrimination when added to a model that included ABP.
No takes yet. Share an insight, caveat, or question.
Skoglund et al. (2015) conducted a cohort in Incident atherosclerotic cardiovascular disease (n=907). NT-proBNP and 24-hour systolic blood pressure vs. Traditional risk factors and office systolic blood pressure was evaluated on Incident ASCVD (fatal or nonfatal myocardial infarction or fatal or nonfatal stroke) (NRI +18.7%-19.9%, p=<0.01). Adding NT-proBNP to ambulatory blood pressure models significantly improved net reclassification for incident ASCVD (+18.7%-19.9%, P<0.01) in elderly men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: